Shouyao Holdings (Beijing) Past Earnings Performance
Past criteria checks 0/6
Shouyao Holdings (Beijing)'s earnings have been declining at an average annual rate of -1.4%, while the Pharmaceuticals industry saw earnings growing at 9% annually. Revenues have been declining at an average rate of 23.8% per year.
Key information
-1.4%
Earnings growth rate
7.9%
EPS growth rate
| Pharmaceuticals Industry Growth | 10.9% |
| Revenue growth rate | -23.8% |
| Return on equity | -24.3% |
| Net Margin | -5,199.6% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Shouyao Holdings (Beijing) makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 4 | -209 | 22 | 220 |
| 30 Jun 24 | 4 | -195 | 22 | 208 |
| 31 Mar 24 | 5 | -192 | 22 | 207 |
| 31 Dec 23 | 5 | -186 | 21 | 202 |
| 30 Sep 23 | 5 | -191 | 21 | 207 |
| 30 Jun 23 | 5 | -183 | 21 | 206 |
| 31 Mar 23 | 2 | -170 | 21 | 202 |
| 31 Dec 22 | 2 | -174 | 21 | 199 |
| 30 Sep 22 | 4 | -160 | 19 | 188 |
| 30 Jun 22 | 8 | -159 | 18 | 186 |
| 31 Mar 22 | 9 | -161 | 19 | 170 |
| 31 Dec 21 | 13 | -145 | 20 | 157 |
| 30 Sep 21 | 11 | -134 | 23 | 134 |
| 31 Mar 21 | 4 | -349 | 263 | 118 |
| 31 Dec 20 | 7 | -330 | 256 | 85 |
| 31 Dec 19 | 12 | -40 | 8 | 44 |
| 31 Dec 18 | 20 | -12 | 10 | 32 |
| 31 Dec 17 | 31 | -4 | 9 | 27 |
Quality Earnings: 688197 is currently unprofitable.
Growing Profit Margin: 688197 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688197 is unprofitable, and losses have increased over the past 5 years at a rate of 1.4% per year.
Accelerating Growth: Unable to compare 688197's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 688197 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-1.2%).
Return on Equity
High ROE: 688197 has a negative Return on Equity (-24.33%), as it is currently unprofitable.